InvestorsHub Logo
Followers 58
Posts 10147
Boards Moderated 1
Alias Born 09/21/2016

Re: None

Thursday, 02/29/2024 10:21:04 AM

Thursday, February 29, 2024 10:21:04 AM

Post# of 462431
We are WAYYYY overdue for new information and solid news....next week would be soon enough...

NEW YORK – February 26, 2024
Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome, schizophrenia and other central nervous system (CNS) diseases, today announced that it will present at the 44th Annual TD Cowen Health Care Conference, March 4-6, 2024. Christopher U Missling, PhD, President & Chief Executive Officer will present the Company in a session scheduled at 1:30 PM (ET) on Monday, March 4th, 2024, at the Boston Marriott Copley Place in Boston, MA.



https://www.anavex.com/post/anavex-life-sciences-to-present-at-the-44th-annual-td-cowen-health-care-conference?mc_cid=a9fbb93a6c&mc_eid=a2160c00e9
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News